Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36 GBX | -5.26% | -6.49% | +56.52% |
08/05 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
20/03 | Cornerstone FS plans to change name to Finseta as part of growth plan | AN |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- Low profitability weakens the company.
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+56.52% | 25.87M | - | ||
+10.63% | 321B | B- | ||
+27.46% | 222B | B+ | ||
+2.33% | 148B | B | ||
+16.49% | 59.26B | D+ | ||
+10.55% | 31.8B | C+ | ||
+1.14% | 29.89B | B+ | ||
+100.06% | 22.41B | D+ | ||
+27.97% | 20.98B | B- | ||
+2.86% | 15.07B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- CSFS Stock
- Ratings Cornerstone FS plc